Galderma Group AG
GALD
Rank in Stocks
#457
Galderma Group AG operates as a dermatology company worldwide. The company... Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Share Price
$224.81
Market Cap
$52.42B
Change (1 day)
6.31%
Change (1 year)
31.28%
Country
CH
Trade Galderma Group AG (GALD)
Category
Healthcare
EPS for Galderma Group AG (GALD)
EPS as of 2026 TTM: 0
According to Galderma Group AG latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Galderma Group AG from 2021 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2025 | $2.72 | 154.21% |
| 2024 | $1.07 | -511.54% |
| 2023 | $-0.26 | -39.53% |
| 2022 | $-0.43 | -33.85% |
| 2021 | $-0.65 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| $0.56 | - |
IN
|
|
| - | - |
CN
|
